Department of Laboratory Hematology, Narayana Hrudayalaya, Bangalore, India.
Bone Marrow Transplantation and Stem Cell Research Centre, IMS, BHU, Varanasi, India.
Cytometry B Clin Cytom. 2023 Nov;104(6):453-459. doi: 10.1002/cyto.b.22119. Epub 2023 Mar 9.
Early T cell precursor-acute lymphoblastic leukemia (ETP-ALL) is a hematolymphoid malignancy where the blasts demonstrate T cell differentiation markers along with stem cell and myeloid antigen expression. The differential diagnosis of ETP-ALL from non-ETP ALL and mixed phenotype acute leukemia is often challenging due to its overlapping immunophenotypic picture with co-expression of myeloid antigens. In this study, we endeavored to describe the immune-phenotype profile of ETP-ALL in our patients and compared the utility of four different scoring systems for better discrimination of these entities.
This retrospective analysis included 31 ETP-ALL out of 860 acute leukemia cases consecutively diagnosed at the two tertiary care centers. Flowcytometry-based immunophenotype was reviewed for all the cases, and the utility of four flow-based objective scorings was assessed for the diagnosis of ETP-ALL. Receiver operating curves were drawn to compare the different flow-based scoring systems.
The prevalence of ETP-ALL was 40% (n = 31/77 T-ALL) in our study group, comprised mainly of adults with a median age of 20 years. The five-marker scoring system had the maximum area under the curve, followed by the seven-marker scoring system. A cut-off of ≥2.5 was more specific (sensitivity: 91%; specificity: 100%), while a score of ≥1.5 was more sensitive but slightly less specific (sensitivity: 94%, specificity: 96%).
The WHO criteria for the diagnosis of ETP-ALL should be followed across all laboratories to avoid confusion and for better treatment stratification. Flow-based scoring systems can be objectively employed for better detection of cases.
早期 T 细胞前体-急性淋巴细胞白血病(ETP-ALL)是一种血液淋巴恶性肿瘤,其中的白血病细胞表现出 T 细胞分化标志物,同时还表达干细胞和髓系抗原。由于其与非 ETP-ALL 和混合表型急性白血病的免疫表型重叠,共同表达髓系抗原,因此 ETP-ALL 的鉴别诊断常常具有挑战性。在本研究中,我们旨在描述我们患者中 ETP-ALL 的免疫表型特征,并比较四种不同评分系统的效用,以更好地区分这些实体。
本回顾性分析包括在两个三级护理中心连续诊断的 860 例急性白血病病例中的 31 例 ETP-ALL。对所有病例进行基于流式细胞术的免疫表型分析,并评估了四种基于流式细胞术的客观评分系统在诊断 ETP-ALL 中的效用。绘制接收者操作曲线以比较不同的基于流式细胞术的评分系统。
在我们的研究组中,ETP-ALL 的患病率为 40%(n=31/77 T-ALL),主要由成年人组成,中位年龄为 20 岁。五项标志物评分系统的曲线下面积最大,其次是七项标志物评分系统。≥2.5 的截断值具有更高的特异性(敏感性:91%;特异性:100%),而≥1.5 的评分更敏感但特异性略低(敏感性:94%,特异性:96%)。
应在所有实验室中遵循 WHO 标准诊断 ETP-ALL,以避免混淆并进行更好的治疗分层。流式细胞术评分系统可客观用于更好地检测病例。